Palmitoylethanolamide - An Overview
In these problems, it has been demonstrated that the increase of endogenous Palmitoylethanolamide—possibly by decreasing its degradation or exogenous administration—is able to continue to keep neuroinflammation within just its physiological limits. With this evaluate the large variety of studies on the benefits derived from oral administration